ABO blood group and chronic pancreatitis risk in the NAPS2 cohort

Pancreas

Volumn 40, Issue 8, 2011, Pages 1188-1194

  Greer, Julia B ^a   Larusch, Jessica ^a   Brand, Randall E ^a,b   O'Connell, Michael R ^a   Yadav, Dhiraj ^a   Whitcomb, David C ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

ABO blood group; blood type; chronic pancreatitis; genetic mutation; inflammation; risk

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; BLOOD GROUP ABO SYSTEM; CHRONIC PANCREATITIS; COHORT ANALYSIS; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; ALCOHOLISM; CARRIER PROTEINS; COHORT STUDIES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; NORTH AMERICA; ODDS RATIO; PANCREATITIS, ALCOHOLIC; PANCREATITIS, CHRONIC; RISK FACTORS; TRYPSIN;

EID: 80054852465     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182232975     Document Type: Conference Paper

References (53)

1. NIDDK. Diseases of the Pancreas. Available at: Http://www2.niddk.nih. gov/NR/rdonlyres/6178C95C-40B3-4052-819F-E251F44ADCB5/0/NCDD-04272009- ResearchPlan-DiseasesofPancreas.pdf. Accessed January 25, 2011.
2. Worning H. Chronic pancreatitis: Pathogenesis, natural history and conservative treatment. Clin Gastroenterol. 1984;13:871-894.
3. Steer ML, Waxman I, Freedman S. Chronic pancreatitis. NEJM. 1995;332:1482-1490.
4. Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Int Med. 2009;169:1035-1045.
5. Etemad B, Whitcomb DC. Chronic pancreatitis: Diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120:682-707.
6. Stevens T, Conwell DL, Zuccaro G. Pathogenesis of chronic pancreatitis: An evidence-based review of past theories and recent developments. Am J Gastroenterol. 2004;99:2256-2270.
7. Schmitt F, Le Henaff G, Piloquet H, et al. Hereditary pancreatitis in children: Surgical implications with special regard to genetic background. J Ped Surg. 2009;44:2078-2082.
8. Secknus R, Mossner J. Changes in incidence and prevalence of acute and chronic pancreatitis in Germany [in German]. Chirurg. 2000;71:249-252.
9. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group [see comment]. NEJM. 1993;328:1433-1437.
10. Raimondi S, Lowenfels AB, Morselli-Labate AM, et al. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol. 2010;24:349-358.
11. Lowenfels AB, Maisonneuve P, DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. JNCI. 1997;89:442-446.
12. Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004;2:252-261.
13. Greer JB, Lynch HT, Brand RE, et al. Hereditary pancreatic cancer: A clinical perspective. Best Pract Res Clin Gastroenterol. 2009;23:159-170.
14. Whitcomb DC. Inflammation and cancer. V. Chronic pancreatitis and pancreatic cancer. Am J Physiol Gastrointest Liver Physiol. 2004;287:G315YG319.
15. Lowenfels AB, Maisonneuve P, Whitcomb DC, et al. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA. 2001;286:169-170.
16. Corrao G, Bagnardi V, Zambon A, et al. Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: A meta-analysis. Addiction. 1999;94: 1551-1573.
17. Frulloni L, Gabbrielli A, Pezzilli R, et al. Chronic pancreatitis: Report from a multicenter Italian survey (PanCroInfAISP) on 893 patients. Dig Liver Dis. 2009;41:311-317.
18. Aoun E, Chang CC, Greer JB, et al. Pathways to injury in chronic pancreatitis: Decoding the role of the high-risk SPINK1 N34S haplotype using meta-analysis. PLoS ONE [Electronic Resource]. 2008;3:e2003.
19. Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19:1893-1907.
20. Greer JB, Whitcomb DC, Brand RE. Genetic predisposition to pancreatic cancer: A brief review. Am J Gastroenterol. 2007;102:2564-2569.
21. Brand RE, Greer JB, Zolotarevsky E, et al. Pancreatic cancer patients who smoke and drink are diagnosed at younger ages. Clin Gastroenterol Hepatol. 2009;7:1007-1012.
22. Brand RE, Lerch MM, Rubinstein WS, et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut. 2007;56:1460-1469.
23. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41:986-990.
24. Wolpin BM, Kraft P, Gross M, et al. Pancreatic cancer risk and ABO blood group alleles: Results from the pancreatic cancer cohort consortium. Cancer Res. 2010;70:1015-1023.
25. Annese V, Minervini M, Gabbrielli A, et al. ABO blood groups and cancer of the pancreas. Int J Pancreatol. 1990;6:81-88.
26. Vioque J, Walker AM. Pancreatic cancer and ABO blood types: A study of cases and controls [in Spanish]. Med Clin. 1991;96:761-764.
27. Wolpin BM, Chan AT, Hartge P, et al. ABO blood group and the risk of pancreatic cancer. JNCI. 2009;101:424-431.
28. Greer JB, Yazer MH, Raval JS, et al. Significant association between ABO blood group and pancreatic cancer. World J Gastroenterol. 2010;16:5588-5591.
29. Whitcomb DC, Yadav D, Adam S, et al. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: The North American Pancreatitis Study 2 (NAPS2). Pancreatology. 2008;8:520-531.
30. Cavestro GM, Zuppardo RA, Bertolini S, et al. Connections between genetics and clinical data: Role of MCP-1, CFTR, and SPINK-1 in the setting of acute, acute recurrent, and chronic pancreatitis. Am J Gastroenterol. 2010;105:199-206.
31. Rebours V, Boutron-Ruault MC, Jooste V, et al. Mortality rate and risk factors in patients with hereditary pancreatitis: Uni- and multidimensional analyses. Am J Gastroenterol. 2009;104:2312-2317.
32. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene [see comment]. Nat Genet. 1996;14:141-145.
33. Whitcomb DC. Mechanisms of disease: Advances in understanding the mechanisms leading to chronic pancreatitis. Nat Clin Pract Gastroenterol Hepatol. 2004;1:46-52.
34. Rebours V, Boutron-Ruault MC, Schnee M, et al. The natural history of hereditary pancreatitis: A national series. Gut. 2009;58:97-103.
35. Maisonneuve P, Lowenfels AB, Mullhaupt B, et al. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. Gut. 2005;54:510-514.
36. Maisonneuve P, Frulloni L, Mullhaupt B, et al. Impact of smoking on patients with idiopathic chronic pancreatitis. Pancreas. 2006;33:163-168.
37. Whitcomb DC. Gene-environment factors that contribute to alcoholic pancreatitis in humans. J Gastroenterol Hepatol. 2006;21(suppl 3): S52YS55.
38. Maisonneuve P, Lowenfels AB. Chronic pancreatitis and pancreatic cancer. Dig Dis. 2002;20:32-37.
39. Greer JB, Whitcomb DC. Inflammation and pancreatic cancer: An evidence-based review. Curr Opin Pharmacol. 2009;9:411-418.
40. Marjolin J. Dictionnaire de Médecine, Volume 21. Pratique. par Nicolas-Philibert Adelon: Paris; 1828.
41. Farrow B, Evers BM. Inflammation and the development of pancreatic cancer. Surg Oncol. 2002;10:153-169.
42. Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene. 1999;18:6938-6947.
43. Farrow B, Sugiyama Y, Chen A, et al. Inflammatory mechanisms contributing to pancreatic cancer development. Ann Surg. 2004;239:763-769; discussion 769-771.
44. Cancer of stomach and blood grouping. Br Med J. 1953;1:828.
45. Edgren G, Hjalgrim H, Rostgaard K, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: A cohort study. Am J Epidemiol. 2010;172:1280-1285.
46. El Hajj II, Hashash JG, Baz EM, et al. ABO blood group and gastric cancer: Rekindling an old fire? South Med J. 2007;100:726-727.
47. Gates MA, Wolpin BM, Cramer DW, et al. ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer. 2011;128: 482-486.
48. Lindkvist B, Johansen D, Borgstrom A, et al. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer. 2008;8:321.
49. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, et al. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. JNCI. 2001;93:937-941.
50. Azevedo M, Eriksson S, Mendes N, et al. Infection by Helicobacter pylori expressing the BabA adhesin is influenced by the secretor phenotype. J Pathol. 2008;215:308-316.
51. Alkout AM, Blackwell CC, Weir DM, et al. Isolation of a cell surface component of Helicobacter pylori that binds H type 2, Lewis(a), and Lewis(b) antigens. Gastroenterology. 1997;112:1179-1187.
52. Risch HA, Yu H, Lu L, et al. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: A case-control study. JNCI. 2010;102:502-505.
53. Mullady DK, Yadav D, Amann ST, et al. Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: A prospective cohort study. Gut. 2011;60:77-84.